Quilizumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Quilizumab
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target IGHE
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
Formula C6492H10046N1728O2023S44
Molar mass 146.1 kg/mol

Quilizumab (INN) is a humanized monoclonal antibody designed for the treatment of asthma.[1] It binds to IGHE.[2]

This drug was developed by Genentech.

References[edit]